• Overview
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
    • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Skip to main content
SeaStar Medical Logo

Executive Management

  • Overview
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
    • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

Executive Management Carousel

Portrait

Eric Schlorff, Chief Executive Officer

Since 2019, Eric Schlorff has Chief Executive Officer of SeaStar Medical, responsible for the management, strategy, and operations of the company. He has extensive experience in financial planning and managing large, complex organizations and as well as deep knowledge of SeaStar Medical’s business operations, including the scientific basis, regulatory requirements and sales and marketing channels.

Prior to joining SeaStar Medical in 2016, Mr. Schlorff spent more than 20 years at Dow Chemical Company, serving in served in multiple role, including Global Director of Alternative Investments for the Dow Chemical Pension Plan, Global Finance Leader for Crop Protection & Seeds at Dow AgroSciences, Global Market Intelligence Leader at Dow AgroSciences, Global Financial Manager of Royalties at Dow Agrosciences, Senior Investment Manager of Alternative Investments at Dow Chemical Company, New Business Development of Pharmaceuticals at Dow Chemical Company, Global Financial Analyst within the New Businesses division at Dow Chemical Company, and Global Financial Analyst within Dow AgroSciences at Dow Chemical Company.

Mr. Schlorff has a bachelor’s degree in chemistry and biology from Mac Murray College, an M.S. in pharmacology from Southern Illinois University School of Medicine and a master’s in business administration from University of Illinois Urbana-Champlain.

Portrait

Col. (Ret) Kevin Chung, MD, FCCM, FACP, Chief Medical Officer

Dr. Kevin Chung, a renowned expert in burns, multi-organ support, and extracorporeal therapies, is Chief Medical Officer of SeaStar Medical where he is responsible for the strategy, direction, and execution of the company’s clinical development plans as the company develops and commercializes extracorporeal therapies.

Prior to joining SeaStar Medical, Dr. Chung served as professor and Chair of the Department of Medicine, and professor of Surgery, at the F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences, Bethesda, Maryland. Earlier in his career, he served as Chief of the Department of Medicine at Brooke Army Medical Center in San Antonio. Dr. Chung deployed as the Chief, Intensive Care Unit, for the 86th Combat Support Hospital in Baghdad, Iraq 2008, and as Director, Joint Combat Casualty Research Team in Bagram, Afghanistan 2012.

He is a 1995 graduate of the United States Military Academy at West Point and a 1999 graduate of Georgetown University School of Medicine.

Dr. Chung has authored over 300 peer reviewed manuscripts, reviews, editorials, and book chapters, and has been an invited speaker for over 150 lectures internationally.

Portrait

Caryl Baron, Interim Chief Financial Officer

Caryl Baron brings a wealth of experience to her role as Finance Controller of SeaStar Medical. She is a senior level financial professional with core strengths in General Ledger oversight, strategic planning, project management, analysis and working through the growing pains of a new or evolving company. Caryl has worked for both large and small companies, public and private, providing leadership in building internal controls, implementing ERP systems, and working on M&A transactions. At SeaStar Medical she has built systems and control environment to support the company’s growth and overall public company-readiness in addition to reducing costs and managing the audit process with outside auditors. Caryl holds a BS, Accounting from University of Maryland.

Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form
  • Corporate Governance

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At SeaStar Medical, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to SeaStar to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Unsubscribe

Email Alert Sign Up Confirmation

SeaStar Medical Logo

Contact Us

LHA Investor Relations
310-691-7100
Jcain@lhai.com

  • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Governance
    • Resources
  • Privacy Policy
  • Terms and Conditions
  • Site Map
© Q4 Inc. - All rights reserved
Powered By Q4 Inc. 5.91.0.8 (opens in new window)